Humedix Co., Ltd. (200670.KQ)

KRW 42800.0

(3.38%)

Revenue Summary of Humedix Co., Ltd.

Humedix Co., Ltd.'s latest annual revenue in 2023 was 152.27 Billion KRW , up 23.63% from previous year.
Humedix Co., Ltd.'s latest quarterly revenue in 2024 Q1 was 41.17 Billion KRW , up 12.08% from previous quarter.
Humedix Co., Ltd. reported a annual revenue of 123.17 Billion KRW in annual revenue 2022, up 10.97% from previous year.
Humedix Co., Ltd. reported a annual revenue of 110.99 Billion KRW in annual revenue 2021, up 12.7% from previous year.
Humedix Co., Ltd. reported a quarterly revenue of 45.86 Billion KRW for 2024 Q2, up 11.39% from previous quarter.
Humedix Co., Ltd. reported a quarterly revenue of 36.11 Billion KRW for 2023 Q1, up 10.51% from previous quarter.

Annual Revenue Chart of Humedix Co., Ltd. (2023 - 2015)

Historical Annual Revenue of Humedix Co., Ltd. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	152.27 Billion KRW	23.63%
2022	123.17 Billion KRW	10.97%
2021	110.99 Billion KRW	12.7%
2020	98.48 Billion KRW	25.26%
2019	78.61 Billion KRW	21.27%
2018	64.83 Billion KRW	18.46%
2017	54.72 Billion KRW	16.11%
2016	47.13 Billion KRW	111767.98%
2015	42.13 Million KRW	0.0%

Year	Revenue	Revenue Growth
2024 Q1	41.17 Billion KRW	12.08%
2024 Q2	45.86 Billion KRW	11.39%
2023 Q1	36.11 Billion KRW	10.51%
2023 Q4	36.73 Billion KRW	-7.36%
2023 FY	152.27 Billion KRW	23.63%
2023 Q3	39.65 Billion KRW	-0.27%
2023 Q2	39.76 Billion KRW	10.09%
2022 Q1	26.85 Billion KRW	-11.57%
2022 Q4	32.68 Billion KRW	2.49%
2022 FY	123.17 Billion KRW	10.97%
2022 Q3	31.89 Billion KRW	0.46%
2022 Q2	31.74 Billion KRW	18.21%
2021 Q3	26.39 Billion KRW	2.27%
2021 Q1	28.41 Million KRW	-18.69%
2021 Q2	25.81 Billion KRW	90724.11%
2021 Q4	30.36 Billion KRW	15.05%
2021 FY	110.99 Billion KRW	12.7%
2020 Q1	19.17 Million KRW	-13.58%
2020 FY	98.48 Billion KRW	25.26%
2020 Q4	34.94 Million KRW	55.85%
2020 Q3	22.42 Million KRW	2.23%
2020 Q2	21.93 Million KRW	14.39%
2019 Q3	21.54 Million KRW	19.32%
2019 Q2	18.05 Million KRW	7.33%
2019 Q1	16.82 Million KRW	-1.44%
2019 FY	78.61 Billion KRW	21.27%
2019 Q4	22.18 Million KRW	2.98%
2018 Q4	17.07 Million KRW	0.98%
2018 FY	64.83 Billion KRW	18.46%
2018 Q1	14.3 Million KRW	0.35%
2018 Q2	16.54 Million KRW	15.69%
2018 Q3	16.9 Million KRW	2.15%
2017 Q2	14.28 Million KRW	13.06%
2017 FY	54.72 Billion KRW	16.11%
2017 Q1	12.63 Million KRW	-9.25%
2017 Q4	14.25 Million KRW	5.14%
2017 Q3	13.55 Million KRW	-5.06%
2016 Q2	11.57 Million KRW	8.07%
2016 Q1	10.71 Million KRW	0.0%
2016 FY	47.13 Billion KRW	111767.98%
2016 Q3	10.92 Million KRW	-5.68%
2016 Q4	13.91 Million KRW	27.45%
2015 FY	42.13 Million KRW	0.0%

Peer Revenue Comparison of Humedix Co., Ltd.

Name	Revenue	Revenue Difference
HLB Pharmaceutical Co., Ltd	135.95 Billion KRW	-12.005%
CMG Pharmaceutical Co., Ltd.	93.9 Billion KRW	-62.154%
Celltrion Pharm, Inc.	388.79 Billion KRW	60.834%
Huons Global Co., Ltd.	758.37 Billion KRW	79.921%
DongKook Pharmaceutical Co., Ltd.	730.99 Billion KRW	79.169%
Enzychem Lifesciences Corporation	76.03 Billion KRW	-100.258%
Boditech Med Inc.	134.21 Billion KRW	-13.452%
EuBiologics Co., Ltd.	69.36 Billion KRW	-119.523%
FutureChem Co.,Ltd	13.96 Billion KRW	-990.161%
Huons Co., Ltd.	552 Billion KRW	72.414%
BNC Korea Co., Ltd.	80.99 Billion KRW	-87.998%
AptaBio Therapeutics Inc.	323.86 Million KRW	-46917.125%